Nostrum Pharmaceuticals, LLC
10Patents
4Active
10Granted
38Portfolio score
Filing activity: Dec 10, 1999 → Feb 12, 2016 · 3 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6946146B2 | Coating for a sustained release pharmaceutical composition | Human Necessities | 70 | Expired |
| US7897179B2 | Pharmaceutical composition containing water soluble drug | Human Necessities | 46 | Active |
| US6635680B2 | Controlled release pellet formulation | Human Necessities | 23 | Expired |
| US7179486B1 | Process for preparing sustained release tablets | Human Necessities | 18 | Expired |
| US6416786B1 | Sustained release tablet containing hydrocolloid and cellulose ether | Human Necessities | 10 | Expired |
| US8906419B2 | Pharmaceutical composition containing water soluble drug | Human Necessities | 6 | Active |
| US8507000B2 | Controlled release formulation of erythromycin derivatives | Human Necessities | 4 | Expired |
| US7052706B2 | Control release formulation containing a hydrophobic material as the sustained release agent | Human Necessities | 1 | Expired |
| US10391419B1 | Isolation and purification of conjugated estrogens | Performing Operations; Transporting | 0 | Active |
| US8545882B2 | Control release formulation containing a hydrophobic material as the sustained release agent | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.